Clinical efficacy and drug resistance of ceftazidime-avibactam in the treatment of Carbapenem-resistant gram-negative bacilli infection

OBJECTIVE: To examine the clinical efficacy, safety, and resistance of Ceftazidime-Avibactam (CAZ-AVI) in patients with Carbapenem-resistant Gram-negative bacilli (CR-GNB) infections. METHODS: We retrospectively analyzed relevant data of CR-GNB infected patients receiving CAZ-AVI treatment, analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Shuang, Fu, Qianwen, Miao, Youhan, Zhao, Manna, Lu, Shengwei, Xu, Jie, Zhao, Weifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469675/
https://www.ncbi.nlm.nih.gov/pubmed/37664109
http://dx.doi.org/10.3389/fmicb.2023.1198926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469675/
https://www.ncbi.nlm.nih.gov/pubmed/37664109
http://dx.doi.org/10.3389/fmicb.2023.1198926

Ejemplares similares